[1]
Yan, B., Li, X., Zhou, L., Qiao, Y., Wu, J., Zha, L., Liu, .P., Peng, S., Wu, B., Yu, X. and Shen, L. 2022. Inhibition of IRAK 1/4 alleviates colitis by inhibiting TLR4/ NF-κB pathway and protecting the intestinal barrier. Bosnian Journal of Basic Medical Sciences. 22, 6 (Oct. 2022), 872–881. DOI:https://doi.org/10.17305/bjbms.2022.7348.